CareDx, Inc
CDNA
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cā¦ read more
Healthcare
Diagnostics & Research
12 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$47.85
Price+9.47%
$4.14
1Y
Price
Market Cap
$2.475b
Mid
Price/Earnings 3y Avg5y Avg
57x
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.+3.3%
EBITDA Margin+83.9%
Net Profit Margin+21.8%
Free Cash Flow Margin+3.3%
EBITDA Margin+83.9%
Net Profit Margin+21.8%
Free Cash Flow MarginRevenue
$458.089m
+20.6%
1y CAGR+17.8%
3y CAGR+10.2%
5y CAGREarnings
$111.012m
+619.9%
1y CAGR+202.3%
3y CAGR+114.6%
5y CAGREPS
$2.07
+617.5%
1y CAGR+200.3%
3y CAGR+113.7%
5y CAGRBook Value
$425.598m
$532.988m
Assets$107.390m
Liabilities$19.247m
DebtDebt to Assets
3.6%
1.2x
Debt to EBITDAFree Cash Flow
$85.046m
+135.5%
1y CAGR+121.4%
3y CAGR+102.1%
5y CAGRNo items found.
Press Releases
Statements and updates from the company